Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02229240 · WITHDRAWN
Trial details
- NCT number
- NCT02229240
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.